Optimising time-limited trials in acute respiratory failure: a multicentre focused ethnography protocol Authors: Jacqueline M Kruser, Douglas A Wiegmann, Nandita R Nadig, Katharine E Secunda, Bret M Hanlon, Joy X Moy, Arsalan Ahmad, Emily G Campbell, Helen K Donnelly, Francisco J Martinez, Madison Polley, Cemre Orhan, Erin Korth, Lily N Stalter, Timothy J Rowe, Andrew L Wu, Elizabeth M Viglianti, Ella C Eisinger, Oliver Nguyen, Scott D Halpern, Justin T Clapp Published: 2025 ABSTRACT AbstractIntroductionThe ‘time-limited trial’ for patients with critical illness is a collaborative plan made by clinicians, patients and families to use life-sustaining therapies for a defined duration. After this period, the patient’s response to therapy informs decisions about continuing recovery-focused care or transitioning to comfort-focused care. The promise of time-limited trials to help navigate the uncertain limits and benefits of life-sustaining therapies has been extensively discussed in the palliative and critical care literature, leading to their dissemination into clinical practice. However, we have little evidence to guide clinicians in how to conduct time-limited trials, leading to substantial variation in how and why they are currently used. The overall purpose of this study is to characterise the features of an optimal time-limited trial through a rich understanding of how they are currently shaping critical care delivery.Methods and analysisWe are conducting an observational, multicentre, focused ethnography of time-limited trials in patients with acute respiratory failure receiving invasive mechanical ventilation in six intensive care units (ICUs) within five hospitals across the US. Study participants include patients, their surrogate decision makers and ICU clinicians. We are pursuing two complementary analyses of this rich data set using the open-ended, inductive approach of constructivist grounded theory and, in parallel, the structured, deductive methods of systems engineering. This cross-disciplinary, tailored approach intentionally preserves the tension between time-limited trials’ conceptual formulation and their heterogeneous, real-world use.Ethics and disseminationThis study has been reviewed and approved by the University of Wisconsin Institutional Review Board (IRB) as the single IRB (ID: 2022-1681; initial approval date 23 January 2023). Our findings will be disseminated through peer-reviewed publication, conference presentations, and summaries for the public.Trial registration numberNCT06042621.Keywords: PALLIATIVE CARE, Adult intensive & critical care, ETHICS (see Medical Ethics), QUALITATIVE RESEARCH STRENGTHS AND LIMITATIONS OF THIS STUDY The multicentre design of this study including six medical intensive care units (ICUs) within five hospitals across the US increases the transferability of our findings. The multicentre design of this study including six medical intensive care units (ICUs) within five hospitals across the US increases the transferability of our findings. The prospective, longitudinal, high-density and multi-modal data collection strategy using focused ethnography increases the rigour of our study and richness of our findings. The prospective, longitudinal, high-density and multi-modal data collection strategy using focused ethnography increases the rigour of our study and richness of our findings. This study uses a novel, cross-disciplinary methodology that synthesises open-ended, inductive methods from ethnography and constructivist grounded theory with structured, deductive tools from systems engineering and health services research. This study uses a novel, cross-disciplinary methodology that synthesises open-ended, inductive methods from ethnography and constructivist grounded theory with structured, deductive tools from systems engineering and health services research. Direct observation of time-limited trials within the ICU setting may introduce observer effects and is highly resource intensive. Direct observation of time-limited trials within the ICU setting may introduce observer effects and is highly resource intensive. Introduction The ‘time-limited trial’ is an approach to patient care that has been widely promoted in the critical and palliative care literatures as a way to help patients with serious illness navigate the uncertain limits and benefits of life-sustaining therapies.1 2 A time-limited trial is a collaborative plan made by clinicians, patients and families to use life-sustaining therapy for a defined duration, after which the patient’s response to therapy informs the decision of whether to continue recovery-focused care or transition to focus exclusively on comfort.2 This approach has been promoted primarily as a tool for achieving certain ethical goals: promoting patient autonomy and addressing the longstanding challenge of reducing non-beneficial therapies near end of life.3,5 The intuitive appeal of time-limited trials has led to their dissemination into clinical practice,6 but with substantial variation in how, why and when they are used.7 8 While time-limited trials have intuitive appeal, their real-world impact will be determined by how they are implemented in clinical practice. Clinicians and scholars have expressed concern that poorly conducted time-limited trials may fail to reach their promise and cause unintended harm, particularly given the social and technical complexity of the intensive care unit (ICU) environment.2 7 9 However, we currently have little empirical evidence to guide the optimal use of this approach.6 With funding from the National Institutes of Health/National Heart Lung and Blood Institute, we are seeking to address this knowledge gap by conducting a multicentre focused ethnography of time-limited trials in patients with acute respiratory failure. The overall purpose of this study is to characterise the features of an optimal time-limited trial through a rich understanding of how they are currently shaping ICU care delivery. This understanding will serve as the foundation for tailored interventions to support their optimal use in clinical practice. Time-limited trials have two features that necessitate a creative methodological approach for investigation. First, because they are already disseminated into clinical practice but with wide variation, we have an opportunity to compare and evaluate various time-limited trial features within the ICU context and before clinical norms converge. However, these poorly formalised and heterogeneous clinical practices also create a challenge for systematic identification and study. Second, unlike more discrete events or interventions, time-limited trials typically unfold over a period of days and across a large social network of patients, families and clinicians. This creates a challenge for adequate observation using standard health services data collection techniques. In this article, we describe a novel observational study design that addresses these challenges by synthesising open-ended, inductive methods from ethnography and constructivist grounded theory with structured, deductive tools from systems engineering and health services research. Methods Study objectives This ethnographic, qualitative study is the first phase of a sequential mixed methods investigation seeking to define the optimal use of time-limited trials (NIH R01HL168474). The specific objective of the first phase is to richly characterise the current processes of time-limited trial care delivery in ICUs across the US to answer the following major research questions: In what scenarios are time-limited trials proposed and used? In what scenarios are time-limited trials proposed and used? How do time-limited trials shape ICU care? How do time-limited trials shape ICU care? To what extent do time-limited trials in clinical practice align with essential elements established through an American Thoracic Society (ATS) expert consensus report?2 To what extent do time-limited trials in clinical practice align with essential elements established through an American Thoracic Society (ATS) expert consensus report?2 Study design Time-limited trials unfold over days in the complex ICU environment and within a social network of patients, families and clinical team members. Adequate characterisation of this process requires longitudinal data collection of multiple interactions and from multiple perspectives. Thus, we are using focused ethnography to characterise time-limited trials in the ICU context. Like traditional ethnography, focused ethnography uses open-ended, multimodal, high-density, qualitative data collection to capture activities of social groups in their everyday settings. But ‘focused’ ethnography scopes the investigation to specific activities (eg, time-limited trials) within specialised settings (eg, the ICU environment), promoting feasibility and alignment with our study objectives.10,12 Study settings This study takes place in six adult medical ICUs in the US, within five hospitals and three health systems in Illinois, Pennsylvania and Wisconsin. ICUs in different geographic regions across the US vary in the intensity and quality of end-of-life care delivery,13 14 and we theorised that this variation could influence the use of time-limited trials.11 Thus, we selected study sites from different US regions (Midwestern/Northeastern) and with hospital referral-region variation in end-of-life ICU care intensity, according to the Dartmouth Atlas of Healthcare.13 These six medical ICUs also vary in other attributes, including patient demographic distribution, hospital catchment area (urban, suburban, rural), ICU size and staffing models (eg, trainees, advanced practice providers), which supports enrollment of a diverse patient sample and observation of time-limited trials within different ICU environments. Before the study, we engaged with clinical leadership and researchers from each site to confirm that time-limited trials are currently used in their ICU and ensure acceptability of and support for the study. None of the study ICUs have standardised protocols or policies related to the use of time-limited trials. One health system that includes three study ICUs implemented an electronic health record (EHR) note template to support time-limited trial documentation nine months prior to the start of the study. As described below, both templated and non-templated EHR documentation about time-limited trials will be collected, analysed and compared in this study. Participants We consider patients, their surrogate decision makers (herein referred to as surrogates), and their ICU team members as research participants in this ethnographic study, though they are involved in different study components. Eligible patients are adults (age >18) with acute respiratory failure receiving invasive mechanical ventilation in a study ICU. Additionally, the patient’s ICU physician must confirm that a time-limited trial is initiated or being actively considered (details below). Respiratory failure is defined by either hypoxaemia (ratio of arterial partial pressure of oxygen (PaO2, or imputed from SpO2) to fractional inspired oxygen <300)15 16 or hypercapnia (partial pressure of carbon dioxide >45 mm Hg). We include patients for whom invasive mechanical ventilation was initiated during or immediately preceding the current hospitalisation (eg, in a study ICU, emergency department, general care floor, another hospital prior to transfer, or by prehospital emergency medical services). The only exclusion criterion is chronic, invasive mechanical ventilation that was initiated prior to the current hospitalisation. Patient participation in the study is limited to collection of their health record data and observation of their care delivery, as eligible patients are unable to participate in research interviews during the study due to critical illness and invasive mechanical ventilation. The primary surrogate(s) for enrolled patients are eligible for participation. Surrogates are identified by the ICU clinical team as the individual(s) responsible for making medical decisions on behalf of the enrolled, critically ill patient who lacks capacity. The primary surrogate (ie, the legally authorised representative) provides written informed consent for their own participation in the research study and, separately, for the patient’s participation. We do not enroll cases if informed consent is not obtained on behalf of both the surrogate and patient. Multiple surrogates may be included as participants for a single patient if the clinical team determines they are equally involved in medical decision making or if the primary surrogate changes over the course of the study period. In these cases, any additional surrogates provide informed consent for their own research participation. For rare cases where patients retain or regain capacity during the direct study contact period, they provide written consent for their own participation or continued participation. Other people from the patient’s social network, such as additional family members and friends, may be present for study activities including ethnographic data collection. When others are present, study staff obtain their informed consent (verbal, with an Institutional Review Board (IRB)-approved waiver of documentation) to be included in the relevant data collection, such as audio recording of an ICU family meeting. During early enrollment, we found that some time-limited trials are proposed very near the end of life (eg, within hours). Our study team reached consensus that it was potentially unacceptable to approach surrogates for research participation in this timeframe. Yet, these cases represent a use of time-limited trials that is important to be characterised. Thus, the IRB approved a waiver of informed consent to collect limited, indirect data about these patients (ie, no study contact/observations/interviews with surrogates or patients). ICU team participants are members of the interprofessional hospital staff caring for an eligible study patient, including advanced practice providers (nurse practitioners/physician assistants), case managers, chaplains, dietitians, nurses, pharmacists, physical and occupational therapists, physicians (attending/fellow/resident), respiratory therapists and social workers. Prior to study start, ICU team members were notified about the study during routine staff meetings and received a study information sheet about their potential participation (ie, interviews, direct observations), with the opportunity to opt out of direct study contact. Identifying time-limited trials We identify patients receiving a time-limited trial by directly querying potentially eligible patients’ ICU physicians. For all patients with acute respiratory failure receiving invasive mechanical ventilation, we send the physician query approximately 48 hours after initiation of ventilation. This 48-hour timeframe was defined based on physician feedback in our pilot study8 and ensures that ICU clinicians have adequate opportunity to consider and plan a time-limited trial with the patient and/or surrogates. Queries are re-sent approximately every seven days for patients who remain eligible to capture later-onset time-limited trials. We conduct queries in person or via EHR message, cell phone text or email (by physician preference). Our ethnographers also maintain a daily presence in each of the study ICUs so that clinical team members can alert them to potential time-limited trials that are initiated before 48 hours of ventilation or in between queries. Additionally, fliers posted in study ICUs encourage team members to notify study staff about any potential time-limited trials. When study staff are alerted to potential time-limited trials, they confirm study eligibility and send a confirmation query to the ICU physician to maintain a consistent case definition. In the query, we provide ICU physicians with an operational definition of a time-limited trial, established through an ATS consensus report.2 Then, we ask whether this approach is being used for the patient, providing the following response options: (1) Yes, a time-limited trial has been initiated, (2) Yes, a time-limited trial is being considered (among clinical team and/or with patient/surrogate) and (3) No. Patients with responses one or two are eligible for inclusion. We emphasise in the physician query that the approach does not require use of the term ‘time-limited trial’, because the term is contested, is not always used, and is sometimes intentionally avoided by clinicians.2 7 Our research team also avoids this term with surrogates and patients, including during the informed consent process. In allowing ICU clinicians to identify relevant cases, we avoid imposing our own classification scheme to determine ‘real’ trials while also providing a practical method to identify eligible cases for enrollment. This pilot-tested query procedure prioritises the ground-up, flexible identification of time-limited trials by frontline clinicians instead of a top-down determination by researchers. These direct queries have the potential to introduce an observer (‘Hawthorne’) effect and influence physicians’ use of time-limited trials. However, our pilot study did not demonstrate any change in the frequency of time-limited trials over a 12-month period of query use.8 Furthermore, this pilot work demonstrated the necessity of directly querying clinicians to identify time-limited trials, as there are no health record orders, documents or other indirect methods that reliably identify their use. Sampling Among eligible cases, we purposively sample for enrollment based on study ICU, initiating physician and patient demographics (age, gender, race, ethnicity) to ensure adequate representation of these characteristics within the final sample. Because we analyse the qualitative data concurrently with enrollment, we also refine our sampling priorities based on emergent findings from the analysis. This iteratively refined sampling approach is guided by the principle of theoretical saturation, which will define when we have reached an adequate sample.17 Theoretical saturation is the point at which collected data can explain variation relevant to the theory being developed. Here, theoretical saturation is the point when our developing theory about the scenarios in which time-limited trials are used and how they shape ICU care is sufficiently robust to explain what happens in newly collected cases. Drawing from several existing focused ethnographic studies related to ICU care, we anticipate reaching saturation after approximately 50 time-limited trial cases.12 18 19 Data collection For cases enrolled into this study, our primary focus of data collection is the period from study enrollment to the end of the time-limited trial, as established by the ICU clinical team (or until patient death). If a trial duration is not specified, we collect data for a maximum of 10 days to reduce participation burden (primarily for patients’ surrogates). All study ethnographers underwent methodological training led by an anthropologist investigator (JTC). Training consisted of selected readings, practice observations with iterative feedback on field notes, practice interviews and continual feedback on collected data. Direct observations Ethnographers conduct daily, direct observation of enrolled patients’ care, focusing on interactions pertinent to time-limited trials. These include formalised interactions (eg, daily rounds) and informal or spontaneous conversations among clinicians, patients, surrogates or other family members. Ethnographers use field notes to document observations.20 We stop direct observations if the patient is transferred out of the study ICU before the previously established ‘end’ of the time-limited trial. Formal family meetings We audio record and transcribe formal meetings between clinicians and surrogates or other family members (and rarely, patients), defined as those scheduled ahead of time and/or occurring in specialised locations in the ICU (eg, family conference rooms). These meetings are also observed by ethnographers who collect field notes about the meeting in addition to the audio recording. Surrogate interviews The primary surrogate for an enrolled patient participates in serial, semi-structured interviews over the course of the time-limited trial, with a maximum frequency of once every three days. If a patient has more than one primary surrogate, interviews are conducted either individually or together, according to participant preference. If the primary surrogate changes during the ICU stay and the new surrogate consents to participate, only the new surrogate is interviewed after the change. Interviews take place in a private space within or near the ICU, via telephone or video conferencing (based on surrogate preference) and are audio recorded and transcribed. The interview guide focuses on surrogates’ (1) Views on the patient’s health condition and goals, (2) Knowledge of and perspectives on the current care plan and (3) Perspectives on the use of life-sustaining therapies (online supplemental Appendix 1). While we stop direct observations once the patient leaves the ICU, we complete previously arranged surrogate interviews if the patient is alive and remains hospitalised. ICU team member interviews We collect individual interviews with different interprofessional ICU team members throughout the course of an enrolled patient’s time-limited trial. We aim to interview ICU team members representing two to three different roles (eg, attending physician, nurse, respiratory therapist) every three days, so shorter cases include two or three total team member interviews and longer cases include more. To avoid disrupting clinical workflow, ICU team member interviews are structured, brief and can occur after the patient dies or is discharged from the ICU. The interview guide focuses on the team member’s knowledge, understanding and perspective on the time-limited trial (online supplemental material Appendix 2). We use a different interview guide with attending ICU physicians that specifically focuses on their unique role of planning and guiding the time-limited trial (online supplemental Appendix 3). Interviews take place in person in a private space within or near the ICU or via telephone, email or video conferencing. Electronic health record data EHR abstraction includes structured data (ie, clinical and demographic characteristics; online supplemental Appendix 4) and health record note text. We abstract note text from all professions and specialties, including history and physical documents (ICU and hospital), daily progress notes from the ICU stay, consultation notes from the ICU stay, hospital discharge summaries, and site-specific note types or templates related to family conferences, advance care planning and time-limited trials. Analysis Our approach to analysis is twofold. The first follows the qualitative methodological standards of constructivist grounded theory. An anthropologist leads this analysis, which is conducted by a team with diverse backgrounds (critical care, healthcare architecture, public health, sociology). The second approach is conducted by a team of systems and human factors engineers. We conduct these two sets of analyses in parallel but with intentional separation, to preserve the tension between the open-ended, inductive orientation of grounded theory and the structured, deductive engineering approach. This allows for emergent findings about a heterogenous clinical practice while simultaneously measuring how well time-limited trials meet existing standards. Constructivist grounded theory Informed by the core tenets of constructivist grounded theory,21 this analysis not only identifies patterns in our data but also seeks to develop an explanatory theory of why and how time-limited trials are used in clinical practice. Ultimately, this theory’s usefulness in shaping clinical practice will depend on our ability to be highly reflexive and to draw on a broad and deep ‘interpretive repertoire’.22 Our diverse, interdisciplinary, collaborative team of researchers helps ensure that we uphold this standard. This approach uses two modes of data analysis. The first is coding to identify patterns that cut across our sample of cases. Codes are identified inductively through annotation and formalised into a codebook for categorising sections of transcripts and fieldnotes. The codebook is tested for reliability and comprehensiveness and to identify areas of ambiguity, revised through discussion, then used to code all data using NVivo software (Lumivero; Denver, Colorado). Once this basic coding is complete, we will conduct focused coding, prioritising codes based on frequency or significance, refining them and synthesising related codes. Second, we create analytic memos for each of our time-limited trial cases. While coding is well suited for identifying patterns across cases, it is inadequate for examining relationships within individual cases. This is particularly relevant for time-limited trials given their longitudinal nature and involvement of numerous individuals. For each case, a member of the research team writes an in-depth summary synthesising all collected data in chronological order. We discuss each of these memos as a group to characterise overarching features of that time-limited trial. Using patterns identified through these two forms of analysis, we are developing a theory using an abductive approach.23 This approach starts with proposing plausible explanations for key observations in the data (eg, unexpected or repeated observations). We then return to the data to evaluate these explanations and assess their level of empirical support. Through this iterative process, we will arrive at a theory that best accounts for our data. We will use this theory to reflect on the ethical goals proposed in support of time-limited trials, including a focus on identifying inconsistencies between these goals and our theory. Systems engineering process analysis Separately, we are conducting a deductive analysis of the ethnographically collected data, informed by the process-oriented fields of human factors and systems engineering. In these and other related fields, an important distinction is made between ‘work-as-imagined’ and ‘work-as-done’.24,28 Work-as-imagined is the planned, aspirational, or idealised version of how tasks and processes should occur, often derived from the perspective of leaders, experts or managers and enacted through protocols or policies. In comparison, work-as-done is the actual activities and their modifications that take place in complex social and technical environments and by the frontline people carrying out the work. Thus, systematically identifying gaps between work-as-imagined and work-as-done and understanding why they arise is a crucial step in improving and optimising complex processes,29 such as those in healthcare. In this study, we are using this conceptual framework and method of gap analysis to compare whether and how time-limited trials observed in this study (work-as-done) align with the aspirational, expert consensus on time-limited trial essential elements published in the recent ATS report (work-as-envisioned).2 Instead of using the term ‘work-as-imagined’, which typically implies a rigid, top-down, hierarchical perspective, we modified the aspirational term in this study to ‘work-as-envisioned’. This modification signifies our acknowledgement that even the expert consensus-based notion of a time-limited trial is still a ground-up, clinician-driven and context-driven approach to a complex clinical scenario instead of a top-down mandate. Specifically, we are using process mapping techniques to analyse TLTs.9 30 This mapping technique illustrates how clinicians, surrogates and interprofessional team members interact within the ICU work system to operationalise a TLT. We first developed a work-as-envisioned process map derived from the ATS report,2 to serve as a visual model of how these elements ideally take place (figure 1). Then, we are using directed, qualitative content analysis31 of the collected ethnographic data to identify whether these elements are present in enrolled patient cases and determine the extent to which the work captured in this study (work-as-done) reflects the work-as-envisioned process map. After developing an initial, deductive codebook based on the ATS elements and their consensus descriptions, a group of systems engineering researchers refined the codes and their criteria as they are applied to study data. This group meets regularly to review codes, refine the codebook and establish consensus codes for relevant sections of data. Once this first round of coding is complete, we will pursue higher-level analysis that includes descriptive statistics (eg, element frequencies) and content analysis of the qualitative data to evaluate how and why TLT elements fall short in real-world practice and also whether this real-world evidence can identify limitations or problems with the work-as-envisioned TLT. To deepen this analysis, we plan to apply the Systems Engineering Initiative for Patient Safety (SEIPS) framework to examine elements of the TLT care process.32 33 The SEIPS model will allow us to evaluate how tools, technology, people, physical environment and organisational context collectively influence TLTs. This planned systems-level analysis will clarify how TLTs function within the complex ICU environment and inform the design of future interventions to promote their consistent and effective use. The work-as-envisioned process model of how a time-limited trial is conducted, derived from an American Thoracic Society consensus report. The process map key within the figure describes the figure icons. EHR, electronic health record; ICU, intensive care unit. Ethics and dissemination The study has been reviewed and approved by the University of Wisconsin IRB. All participants provided informed consent, with one waiver of consent granted by the IRB and described in the participants section. We will disseminate our findings through peer-reviewed publication in medical and social scientific journals, presentations at academic conferences, and summaries with lay interpretation in public-facing media. Patient and public involvement Prior to submission of the proposal for grant funding of this study, we met with the Community Advisors on Research Design and Strategies group at the University of Wisconsin School of Nursing. This group of community members refined our plan for real-time surrogate interviewing in the ICU to ensure acceptability. Refinements included a minimum of 72 hours between interviews and offering video conference interviews to increase participation. Since starting the study, we have convened a Community Advisory Board (CAB) specific to our programme of research. The CAB has nine standing members, who bring a diverse set of personal experiences with healthcare, including as surrogate decision makers for previous ICU patients. We meet bi-annually with this standing CAB who reviews study progress, including discussion topics such as the use of the ‘time-limited trial’ terminology with patients and families and improving our research approach strategies for eligible patients and families in the ICU. Discussion We are conducting a multicentre, focused ethnography of time-limited trials in ICUs across the US to build a rich understanding of how they currently shape care delivery and to help define their optimal use. Our approach intentionally combines open-ended, inductive methods from ethnography and constructivist grounded theory with structured, deductive tools from systems engineering and health services research. This cross-disciplinary, tailored approach intentionally preserves the tension of the time-limited trial as an intuitively appealing model and as an already disseminating, heterogeneous clinical practice. Our study design addresses the underappreciated challenge of investigating rapidly disseminating innovations in critical care medicine. While slow dissemination of knowledge into clinical practice is a well-known problem,34 some new ideas move into clinical practice surprisingly fast.35 Like the time-limited trial, these ideas take hold early because of their conceptual appeal but lack supporting evidence. For example, use of telemedicine for remote monitoring of ICU patients rapidly expanded in the early 2000s, driven by its intuitive appeal as a strategy to increase access to specialised intensivists.36 Only after its widespread uptake did investigators start to characterise its results and build a richer understanding of how best to position telemedicine within the existing ICU care delivery system.37 38 Studying these innovations early as they spread into practice is important to ensure they reach their promise and avoid unintended harm or wasted resources. Yet, methodologies from the traditional evidence-to-practice continuum are of questionable fit. Overly rigid and deductive methods will miss or override important details related to why, when and how innovations are being used. Conversely, overly open-ended methods are inefficient and risk being too vague to learn from an existing set of practices. We have designed an approach that strikes a balance between these poles, combining methods from disciplines with different intrinsic orientations—deductive and structured with inductive and open-ended. Our approach has limitations to consider. First, there is potential for observer effects (‘Hawthorne effect’) whereby participants change their behaviour because they are being observed. In our pilot study, we did not find any trends in time-limited trial use that would suggest a strong observer effect.8 Given this—and the general difficulty of changing clinician behaviour, as documented in implementation science literature on critical care39 40—we suspect observer effects will have a limited impact on our findings. If present, observer effects would likely promote more frequent or robust trials. Furthermore, observer effects can add richness to findings when these behaviour alterations are identified and incorporated into the analysis.41 Second, our prioritisation of direct observation of multiple clinical practice environments is resource intensive. We contend this investment is the necessary next step to develop interventions that will effectively improve time-limited trials. Otherwise, future (more costly) interventional studies are unlikely to succeed. Third, in part because of the resources required, we have focused this study on the ICU environment and on patients with acute respiratory failure receiving invasive mechanical ventilation. While this is one of the most common settings for time-limited trials, these trials are used in other contexts and our findings may not be transferable. Ultimately, we anticipate that this multicentre, focused ethnography will help define the optimal time-limited trial care delivery processes for patients with acute respiratory failure. Our analysis will also uncover vulnerabilities and unintended harms of time-limited trials. This rich understanding will serve as the foundation for tailored interventions to support and guide the optimal use of time-limited trials in clinical practice. Supplementary material Acknowledgements We would like to acknowledge our standing Community Advisory Board members for their contributions to, and advising on, this study. We are grateful for their perspectives which have improved this work. We’d like to acknowledge the following board members who have provided permission to be named: Aida Padek; Catalina M. Cabello; Francisco Guerrero; Jayme Sopha (Director, Marquette County Health Department); Jenny Shult Huffman; Pa Z. Yang; Robin Carufel (Tribal Health Advisor, Lac du Flambeau, Wisconsin). We would also like to thank and acknowledge the study’s scientific advisors who have informed the study design and approach: Margaret (Gretchen) L Schwarze, MD, MPP; Robert M Arnold, MD; Jane L Holl, MD, MPH; and Theodore (Jack) Iwashyna, MD, PhD. Footnotes Funding: Research reported in this manuscript was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award numbers R01HL168474 and K23HL146890. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2025-106483). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details. References Supplementary Materials